FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to haematological research in oncogynecology, and can be used in patients with cervical cancer recurrences to evaluate effectiveness of anti-tumour treatment and predict tumour process course. Essence of the invention consists in the following: after each course of polychemotherapy standard deviation of volume of neutrophils - SDVNe, lymphocytes - SDVLy and monocytes - SDVMo is determined in peripheral blood, values of coefficients SDVNe×SDVLy/100, SDVNe×SDVMo/100 and SDVLy×SDVMo/100 are calculated, and if values of each of the said coefficients are lower than 3.5, positive effect of anti-tumour therapy and favourable prognosis are predicted, if values of the coefficients are higher than 3.5, low efficiency of treatment and negative prognosis of disease course are predicted. The claimed invention is characterised by high self-descriptiveness, simplicity of implementation, possibility of multiple repetition of the test and does not require special financial expenditures.
EFFECT: method makes it possible to realise selection of the most rational method of anti-tumour impact and minimise development of a number of side effects, including depression of haematopoiesis, in due time.
1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS AND CLINICAL COURSE OF NEOPLASTIC PROCESS IN PATIENTS WITH NASOPHARYNGEAL CARCINOMA | 2012 |
|
RU2526830C2 |
| RECURRENT AND METASTASING CERVICAL CARCINOMA TREATMENT EFFECTIVENESS PREDICTION METHOD | 2007 |
|
RU2353928C1 |
| METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS OF PATIENTS WITH NON-HODGKIN LYMPHOMAS WITH BONE MARROW INVOLVEMENT | 2012 |
|
RU2526796C2 |
| METHOD OF PREDICTING UNFAVOURABLE COURSE OF LOCALLY SPREAD FORMS OF HUMAN PAPILLOMA VIRUS-ASSOCIATED CERVICAL CANCER | 2012 |
|
RU2504326C1 |
| METHOD OF CONTROL OF EFFICIENCY OF ANTITUMOR TREATMENT OF WOMEN WITH MALIGNANT GENITALIA TUMORS | 1999 |
|
RU2170433C2 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF RECURRENCE OF DIFFUSE LARGE B-CELL LYMPHOMA | 2021 |
|
RU2758126C1 |
| METHOD OF TREATING PATIENTS SUFFERING LOCALLY ADVANCED CERVICAL CANCER | 2014 |
|
RU2547569C1 |
| METHOD OF FORECASTING OF AUTOHEMOCHEMIOTHERAPY EFFICIENCY AT PATIENTS WITH RELAPSES AND METASTASISES OF UTERUS NECK CANCER | 2007 |
|
RU2352942C1 |
| METHOD OF NEOADJUVANT TREATMENT OF PATIENTS WITH LOCALLY ADVANCED CERVICAL CANCER | 2017 |
|
RU2648642C1 |
| METHOD FOR PREDICTION OF CERVICAL CANCER METASTASES | 2010 |
|
RU2436102C1 |
